Acute Migraine Treatment with Triptans: Evidence‑Based Dosing and Use Guidelines

General Recommendations

• Initiate oral triptans at standard doses (e.g., sumatriptan 50–100 mg, rizatriptan 10 mg, zolmitriptan 2.5–5 mg, almotriptan 12.5 mg) as soon as the headache is mild; a single repeat dose may be taken after 2 hours if needed, but total use should not exceed 2 treatment days per week to avoid medication‑overuse headache. 1

Timing Principles

• For maximal efficacy, administer a triptan early in the attack while pain is still mild; therapeutic gain declines markedly when treatment is delayed until moderate‑to‑severe pain. 1
• Triptans should not be taken during the aura phase, as no evidence supports benefit in that period. 1

Adjunctive Therapy

• In patients experiencing nausea or vomiting, add an oral pro‑kinetic anti‑emetic such as domperidone or metoclopramide to improve tolerability of triptan therapy. 1

Common Pitfalls

• Avoid prescribing oral ergot alkaloids, opioids, or barbiturates for acute migraine because they have limited efficacy, higher adverse‑event rates, and risk of dependence. 1

Specific Triptan Dosing

Sumatriptan

• Oral: 25–100 mg at headache onset; may repeat after 2 hours; maximum 200 mg per 24 h. 2
• Subcutaneous: 6 mg single injection; may repeat after 1 hour; maximum 12 mg per 24 h. 2
• Intranasal: 5–10 mg (one‑to‑two sprays) in one nostril; may repeat after 2 hours; maximum 40 mg per day. 2
• The subcutaneous formulation reaches peak plasma concentrations in ≈15 minutes, making it the fastest‑acting option and preferred for patients who develop rapid pain escalation, have severe vomiting, or have failed all oral triptans. 2

Rizatriptan

• Oral tablets: Peak plasma concentration achieved in 60–90 minutes, faster than most other triptans. 2
• Available as an absorbable wafer (Maxalt MLT) for individuals with marked nausea or vomiting, providing a non‑oral route of delivery. 2

Naratriptan

• Oral: 1.0–2.5 mg every 4 hours; dosing limits per 24 h as specified in product labeling. 2
• Possesses the longest half‑life among triptans, which may reduce the frequency of headache recurrence. 2

Repeat Dosing & Frequency Limits

• If headache recurs (typically within 8–12 hours after the initial dose), a second dose of the same triptan may be administered. 2

Trial‑and‑Error Approach

• When a given triptan does not provide adequate relief, try a different triptan before abandoning the drug class. 2
• Patients should evaluate a triptan over 2–3 migraine attacks before deeming it ineffective. 2
• Lack of response to one triptan does not predict failure of another, reflecting pharmacologic heterogeneity within the class. 2
• Selection of a specific triptan should align its onset speed, duration of action, and formulation with the patient’s typical attack pattern and therapeutic needs. 2

Absolute Contraindications (selected)

• Recent use (within 24 hours) of another triptan or an ergotamine‑containing medication is prohibited. 2

Triptan Availability and Usage Guidelines

Introduction to Triptan Availability

• The American Academy of Neurology acknowledges that triptan availability varies significantly between countries, and prescribers should verify local formulary access before prescribing 3, 4

Practical Approach for Prescribers

• The American Headache Society recommends starting by confirming which specific triptans and formulations are registered with the local FDA and available through pharmacies, as this will determine actual prescribing options 3
• The European Neurological Society notes that sumatriptan is typically the most widely available triptan internationally due to its status as the first-in-class medication and availability of generic formulations, with subcutaneous injection of 6 mg for patients who rapidly reach peak intensity, experience severe vomiting, or have failed all oral triptans 3, 4, 5

Treatment Guidelines

• The American College of Physicians recommends using triptans as second-line therapy after NSAIDs fail to provide adequate relief, taking them early in the attack when the headache is still mild for maximum effectiveness, but not during the aura phase 3, 4, 5, 6

Contraindications and Precautions

• The American Heart Association advises excluding patients with ischemic heart disease, previous myocardial infarction, uncontrolled hypertension, basilar or hemiplegic migraine, history of stroke or TIA, peripheral vascular disease, or concurrent use with ergotamines or MAO inhibitors before prescribing triptans 5

Medication Usage and Limitations

• The National Institute of Neurological Disorders and Stroke recommends limiting triptan use to no more than 2 days per week, as using acute medications more frequently can lead to medication overuse headache and daily headaches 5